1. Bennett, A., Charl i er, E.M., McDonald, A.M., Simpson, J.S., Stamford, I.F. and Zebro, T. (1977). Prostaglandins and breast cancer. Lancet ii, 624¬626.
2. Bennett, A., Houghton, J., Leaper, D.S. and Stamford, I.F. (1979). Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins, 17, 179–191.
3. Bennett, A., Berstock, D.A. and Carroll, M.A. (1982). Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. Br. J. Cancer, 45, 762–768.
4. Bennett, A., Gaffen, J.D., Melhuish, P.B. and Stamford, I.F. (1987). Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate. Br. J. Pharmacol, 91: 229–235.
5. Bennett A., Gaffen J.D. and Chambers, E. (1988). Cyclo-oxygenase inhibitors and cell killing by cytotoxic drugs. In: Proceedings of the Taipei Conference on Prostaglandin and Leukotriene Research, in press.